08/07/2026
What if the most effective entry point into psychedel*c-assisted therapy for substance use isn't abstinence, but honest, compassionate curiosity about why someone uses?
This November, InnerMost and Journey Clinical Inc. are co-hosting a three-day clinical intensive at the intersection of harm reduction and psychedel*c-assisted therapy. Led by Andrew Tatarsky, PhD—developer of Integrative Harm Reduction Psychotherapy—and Casey Paleos, MD, co-founder and Chief Medical Officer of InnerMost.
50 spots. CE credits available. Early bird pricing through September 5—use code EARLYBIRD10 for 10% off.
Registration link: https://luma.com/IHRPxPAT
Full training guide: https://canva.link/frgdkg313h56gov
Swipe to learn more about the training and facilitators 👉